Treace Medical Concepts logo

Treace Medical ConceptsNASDAQ: TMCI

Profile

Sector:

Healthcare

Country:

United States

IPO:

23 April 2021

Next earnings report:

08 August 2024

Last dividends:

N/A

Next dividends:

N/A
$403.05 M
-76%vs. 3y high
64%vs. sector
-vs. 3y high
-vs. sector
-87%vs. 3y high
73%vs. sector
-89%vs. 3y high
39%vs. sector

Price

after hours | Wed, 03 Jul 2024 20:38:03 GMT
$6.50-$0.37(-5.39%)

Dividend

No data over the past 3 years
$51.11 M$43.00 M
$51.11 M-$18.68 M

Analysts recommendations

Institutional Ownership

TMCI Latest News

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Treace Medical Concepts, Inc. - TMCI
accesswire.com09 June 2024 Sentiment: NEGATIVE

NEW YORK, NY / ACCESSWIRE / June 9, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Treace Medical Concepts, Inc. ("Treace" or the "Company") (NASDAQ:TMCI). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Treace Medical Concepts, Inc. - TMCI
prnewswire.com07 June 2024 Sentiment: NEGATIVE

NEW YORK , June 7, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Treace Medical Concepts, Inc. ("Treace" or the "Company") (NASDAQ: TMCI). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Treace Medical Concepts, Inc. - TMCI
globenewswire.com05 June 2024 Sentiment: NEGATIVE

NEW YORK, June 05, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NASDAQ: TMCI). Such investors are advised to contact Danielle Peyton at [email protected]  or 646-581-9980, ext. 7980.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Treace Medical Concepts, Inc. - TMCI
prnewswire.com30 May 2024 Sentiment: NEGATIVE

NEW YORK , May 30, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Treace Medical Concepts, Inc. ("Treace" or the "Company") (NASDAQ: TMCI). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

Treace to Present at Truist Securities MedTech Conference
globenewswire.com28 May 2024 Sentiment: POSITIVE

PONTE VEDRA, Fla., May 28, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities through its flagship Lapiplasty ® and Adductoplasty ® Procedures, today announced that John T.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Treace Medical Concepts, Inc. - TMCI
prnewswire.com22 May 2024 Sentiment: NEGATIVE

NEW YORK , May 22, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Treace Medical Concepts, Inc. ("Treace" or the "Company") (NASDAQ: TMCI). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Treace Medical Concepts, Inc. (TMCI)
businesswire.com17 May 2024 Sentiment: NEGATIVE

The law firm Kirby McInerney LLP is looking into possible claims against Treace Medical Concepts, Inc. regarding potential violations of federal securities laws or other unlawful business practices. The investigation follows Treace's recent financial report for the first quarter of 2024. Click here for more information on the investigation.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Treace Medical Concepts, Inc. - TMCI
prnewswire.com16 May 2024 Sentiment: NEGATIVE

Pomerantz LLP is looking into allegations on behalf of investors in Treace Medical Concepts, Inc. (NASDAQ: TMCI). Investors with concerns are encouraged to reach out to Danielle Peyton at [email protected] or 646-581-9980, ext.

Treace to Report First Quarter 2024 Financial Results
GlobeNewsWire09 April 2024 Sentiment: NEGATIVE

Company will be hosting a conference call on Tuesday, May 7, 2024 at 4:30 pm ET.

Treace Medical Concepts Inc (TMCI) Q4 2023 Earnings Call Transcript
Seeking Alpha28 February 2024 Sentiment: POSITIVE

Treace Medical Concepts Inc (TMCI) Q4 2023 Earnings Call Transcript

What type of business is Treace Medical Concepts?

Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical improvement. The company also provides Lapiplasty Mini-Incision precision system. In addition, it offers products to address ancillary surgical procedures, including akin osteotomies, weil osteotomies, intercuneiform stabilization, lesser tarsometatarsal joint fusions, and autograft bone harvesting, as well as for MTP fusion. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra Beach, Florida.

What sector is Treace Medical Concepts in?

Treace Medical Concepts is in the Healthcare sector

What industry is Treace Medical Concepts in?

Treace Medical Concepts is in the Medical Devices industry

What country is Treace Medical Concepts from?

Treace Medical Concepts is headquartered in United States

When did Treace Medical Concepts go public?

Treace Medical Concepts initial public offering (IPO) was on 23 April 2021

What is Treace Medical Concepts website?

https://www.treace.com

Is Treace Medical Concepts in the S&P 500?

No, Treace Medical Concepts is not included in the S&P 500 index

Is Treace Medical Concepts in the NASDAQ 100?

No, Treace Medical Concepts is not included in the NASDAQ 100 index

Is Treace Medical Concepts in the Dow Jones?

No, Treace Medical Concepts is not included in the Dow Jones index

When does Treace Medical Concepts report earnings?

The next expected earnings date for Treace Medical Concepts is 08 August 2024